Beckman Coulter Pulls Troponin Assays From Market
Beckman Coulter is pulling a portion of its cardiac troponin assays from the market in response to FDA scrutiny, the firm said April 12
Beckman Coulter is pulling a portion of its cardiac troponin assays from the market in response to FDA scrutiny, the firm said April 12